Minerva Surgical, Inc.
Symbool: UTRS
NASDAQ
0.55
USDMarktprijs vandaag
-0.0002
Koers/Winst Verhouding
-0.0000
Koers/Winst Groei Verhouding
4.88M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Minerva Surgical, Inc. (UTRS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6.9 | 40.6 | 17.4 | ||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.net-receivables | 0 | 7.2 | 7.3 | 8.4 | ||||
balance-sheet.row.inventory | 0 | 16.9 | 15.7 | 10.2 | ||||
balance-sheet.row.other-current-assets | 0 | 4.5 | 4.1 | 0.4 | ||||
balance-sheet.row.total-current-assets | 0 | 36.1 | 75 | 45.4 | ||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.3 | 4.6 | 2.9 | ||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.intangible-assets | 0 | 26.8 | 35 | 43.1 | ||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 26.8 | 35 | 43.1 | ||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 0.5 | 0.6 | ||||
balance-sheet.row.total-non-current-assets | 0 | 32.8 | 40.1 | 46.6 | ||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-assets | 0 | 68.9 | 115.1 | 92 | ||||
balance-sheet.row.account-payables | 0 | 2.8 | 3.6 | 3.5 | ||||
balance-sheet.row.short-term-debt | 0 | 2.2 | 0.2 | 1.7 | ||||
balance-sheet.row.tax-payables | 0 | 0.3 | 0.7 | 0.8 | ||||
balance-sheet.row.long-term-debt-total | 0 | 37.4 | 39.3 | 95.6 | ||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||
balance-sheet.row.other-current-liab | 0 | 8.9 | 18.6 | 27.9 | ||||
balance-sheet.row.total-non-current-liabilities | 0 | 37.4 | 48.4 | 280.6 | ||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.capital-lease-obligations | 0 | 0.4 | 0 | 0 | ||||
balance-sheet.row.total-liab | 0 | 51.7 | 71 | 313.9 | ||||
balance-sheet.row.preferred-stock | 0 | 0 | 115.1 | 0 | ||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.retained-earnings | 0 | -283.7 | -249.6 | -228.1 | ||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-total-stockholders-equity | 0 | 300.8 | 178.5 | 6.3 | ||||
balance-sheet.row.total-stockholders-equity | 0 | 17.2 | 44.1 | -221.8 | ||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 68.9 | 115.1 | 92 | ||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-equity | 0 | 17.2 | 44.1 | -221.8 | ||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||
Total Investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-debt | 0 | 39.7 | 39.3 | 97.3 | ||||
balance-sheet.row.net-debt | 0 | 32.7 | -1.3 | 79.9 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -34.1 | -21.5 | -18.3 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 10.8 | 10.6 | 7.1 | ||||
cash-flows.row.deferred-income-tax | 0 | 0 | -19.4 | -0.1 | ||||
cash-flows.row.stock-based-compensation | 0 | 7 | 6.8 | 0.9 | ||||
cash-flows.row.change-in-working-capital | 0 | -11.1 | -8.5 | -2.9 | ||||
cash-flows.row.account-receivables | 0 | 0 | 1.1 | -4.4 | ||||
cash-flows.row.inventory | 0 | -4.1 | -9.1 | 1.3 | ||||
cash-flows.row.account-payables | 0 | -0.9 | 3.3 | -0.7 | ||||
cash-flows.row.other-working-capital | 0 | -6.1 | -3.9 | 1 | ||||
cash-flows.row.other-non-cash-items | 0 | -8.2 | 9.6 | 1.1 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.6 | -0.5 | ||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -15 | ||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | -25 | 0 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.1 | -25.6 | -15.5 | ||||
cash-flows.row.debt-repayment | 0 | 0 | -35.4 | 0 | ||||
cash-flows.row.common-stock-issued | 0 | 0 | 70.7 | 0.1 | ||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-financing-activites | 0 | -5 | 35.9 | 18 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5 | 71.2 | 18.1 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||
cash-flows.row.net-change-in-cash | 0 | -40.6 | 23.2 | -9.6 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 7.8 | 48.4 | 25.2 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 48.4 | 25.2 | 34.8 | ||||
cash-flows.row.operating-cash-flow | 0 | -35.6 | -22.4 | -12.2 | ||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.6 | -0.5 | ||||
cash-flows.row.free-cash-flow | 0 | -35.6 | -23 | -12.7 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 50.3 | 52.1 | 37.8 | ||||
income-statement-row.row.cost-of-revenue | 0 | 23.1 | 21.6 | 18.6 | ||||
income-statement-row.row.gross-profit | 0 | 27.2 | 30.5 | 19.1 | ||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.research-development | 0 | - | - | - | ||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.other-expenses | 0 | -0.1 | -0.3 | 0.1 | ||||
income-statement-row.row.operating-expenses | 0 | 58.1 | 59.7 | 34.5 | ||||
income-statement-row.row.cost-and-expenses | 0 | 81.2 | 81.2 | 53.2 | ||||
income-statement-row.row.interest-income | 0 | 0.1 | 0 | 0.1 | ||||
income-statement-row.row.interest-expense | 0 | 3.2 | 11.7 | 12.1 | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.2 | 7.7 | -3 | ||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||
income-statement-row.row.other-operating-expenses | 0 | -0.1 | -0.3 | 0.1 | ||||
income-statement-row.row.total-operating-expenses | 0 | -3.2 | 7.7 | -3 | ||||
income-statement-row.row.interest-expense | 0 | 3.2 | 11.7 | 12.1 | ||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 10.3 | 7.2 | ||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||
income-statement-row.row.operating-income | 0 | -30.9 | -29.1 | -15.4 | ||||
income-statement-row.row.income-before-tax | 0 | -34.1 | -21.5 | -18.4 | ||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | -0.1 | ||||
income-statement-row.row.net-income | 0 | -34.1 | -21.5 | -18.3 |
Vaak gestelde vragen
Wat is Minerva Surgical, Inc. (UTRS) totale activa?
Minerva Surgical, Inc. (UTRS) totale activa is 68900000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.542.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.688.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.566.
Wat is Minerva Surgical, Inc. (UTRS) nettowinst (netto-inkomen)?
De nettowinst is -34112000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 39690000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 58141000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.